世界の白血病がん市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Leukemia Cancer Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3401 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、白血病がんのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、標的療法、生物学的療法、幹細胞移植）、用途別市場規模（急性骨髄性白血病（AML）、慢性骨髄性白血病（CML）、急性リンパ芽球性白血病（ALL）、慢性リンパ性白血病（CLL））、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・白血病がんの市場動向 ・企業の競争状況、市場シェア ・白血病がんの種類別市場規模（化学療法、放射線療法、標的療法、生物学的療法、幹細胞移植） ・白血病がんの用途別市場規模（急性骨髄性白血病（AML）、慢性骨髄性白血病（CML）、急性リンパ芽球性白血病（ALL）、慢性リンパ性白血病（CLL）） ・白血病がんの北米市場規模2016-2027（アメリカ、カナダ） ・白血病がんのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・白血病がんのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・白血病がんの中南米市場規模2016-2027（メキシコ、ブラジル） ・白血病がんの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Biogen、GSK、Novartis、Pfizer、Roche、Takeda Oncology、Teva Pharmaceutical、Celgene、Daiichi Sankyo、EISAI、Sunesis Pharmaceuticals、Bristol-Myers Squibb、Spectrum Pharmaceuticals） ・結論

Market Analysis and Insights: Global Leukemia Cancer Market
The global Leukemia Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Leukemia Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Leukemia Cancer market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Leukemia Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Leukemia Cancer market.

Global Leukemia Cancer Scope and Market Size
Leukemia Cancer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Leukemia Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy
Radiation Therapy
Targeted Therapy
Biological Therapy
Stem Cell Transplant

Segment by Application
Acute Myeloid Leukaemia (AML)
Chronic Myeloid Leukaemia (CML)
Acute Lymphoblastic Leukaemia (ALL)
Chronic Lymphocytic Leukaemia (CLL)

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Biogen
GSK
Novartis
Pfizer
Roche
Takeda Oncology
Teva Pharmaceutical
Celgene
Daiichi Sankyo
Pfizer
Roche

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Leukemia Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Radiation Therapy
1.2.4 Targeted Therapy
1.2.5 Biological Therapy
1.2.6 Stem Cell Transplant
1.3 Market by Application
1.3.1 Global Leukemia Cancer Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Acute Myeloid Leukaemia (AML)
1.3.3 Chronic Myeloid Leukaemia (CML)
1.3.4 Acute Lymphoblastic Leukaemia (ALL)
1.3.5 Chronic Lymphocytic Leukaemia (CLL)
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Leukemia Cancer Market Perspective (2016-2027)
2.2 Leukemia Cancer Growth Trends by Regions
2.2.1 Leukemia Cancer Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Leukemia Cancer Historic Market Share by Regions (2016-2021)
2.2.3 Leukemia Cancer Forecasted Market Size by Regions (2022-2027)
2.3 Leukemia Cancer Industry Dynamic
2.3.1 Leukemia Cancer Market Trends
2.3.2 Leukemia Cancer Market Drivers
2.3.3 Leukemia Cancer Market Challenges
2.3.4 Leukemia Cancer Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Leukemia Cancer Players by Revenue
3.1.1 Global Top Leukemia Cancer Players by Revenue (2016-2021)
3.1.2 Global Leukemia Cancer Revenue Market Share by Players (2016-2021)
3.2 Global Leukemia Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Leukemia Cancer Revenue
3.4 Global Leukemia Cancer Market Concentration Ratio
3.4.1 Global Leukemia Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Leukemia Cancer Revenue in 2020
3.5 Leukemia Cancer Key Players Head office and Area Served
3.6 Key Players Leukemia Cancer Product Solution and Service
3.7 Date of Enter into Leukemia Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Leukemia Cancer Breakdown Data by Type
4.1 Global Leukemia Cancer Historic Market Size by Type (2016-2021)
4.2 Global Leukemia Cancer Forecasted Market Size by Type (2022-2027)

5 Leukemia Cancer Breakdown Data by Application
5.1 Global Leukemia Cancer Historic Market Size by Application (2016-2021)
5.2 Global Leukemia Cancer Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Leukemia Cancer Market Size (2016-2027)
6.2 North America Leukemia Cancer Market Size by Type
6.2.1 North America Leukemia Cancer Market Size by Type (2016-2021)
6.2.2 North America Leukemia Cancer Market Size by Type (2022-2027)
6.2.3 North America Leukemia Cancer Market Size by Type (2016-2027)
6.3 North America Leukemia Cancer Market Size by Application
6.3.1 North America Leukemia Cancer Market Size by Application (2016-2021)
6.3.2 North America Leukemia Cancer Market Size by Application (2022-2027)
6.3.3 North America Leukemia Cancer Market Size by Application (2016-2027)
6.4 North America Leukemia Cancer Market Size by Country
6.4.1 North America Leukemia Cancer Market Size by Country (2016-2021)
6.4.2 North America Leukemia Cancer Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Leukemia Cancer Market Size (2016-2027)
7.2 Europe Leukemia Cancer Market Size by Type
7.2.1 Europe Leukemia Cancer Market Size by Type (2016-2021)
7.2.2 Europe Leukemia Cancer Market Size by Type (2022-2027)
7.2.3 Europe Leukemia Cancer Market Size by Type (2016-2027)
7.3 Europe Leukemia Cancer Market Size by Application
7.3.1 Europe Leukemia Cancer Market Size by Application (2016-2021)
7.3.2 Europe Leukemia Cancer Market Size by Application (2022-2027)
7.3.3 Europe Leukemia Cancer Market Size by Application (2016-2027)
7.4 Europe Leukemia Cancer Market Size by Country
7.4.1 Europe Leukemia Cancer Market Size by Country (2016-2021)
7.4.2 Europe Leukemia Cancer Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Leukemia Cancer Market Size (2016-2027)
8.2 Asia-Pacific Leukemia Cancer Market Size by Type
8.2.1 Asia-Pacific Leukemia Cancer Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Leukemia Cancer Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Leukemia Cancer Market Size by Type (2016-2027)
8.3 Asia-Pacific Leukemia Cancer Market Size by Application
8.3.1 Asia-Pacific Leukemia Cancer Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Leukemia Cancer Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Leukemia Cancer Market Size by Application (2016-2027)
8.4 Asia-Pacific Leukemia Cancer Market Size by Region
8.4.1 Asia-Pacific Leukemia Cancer Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Leukemia Cancer Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Leukemia Cancer Market Size (2016-2027)
9.2 Latin America Leukemia Cancer Market Size by Type
9.2.1 Latin America Leukemia Cancer Market Size by Type (2016-2021)
9.2.2 Latin America Leukemia Cancer Market Size by Type (2022-2027)
9.2.3 Latin America Leukemia Cancer Market Size by Type (2016-2027)
9.3 Latin America Leukemia Cancer Market Size by Application
9.3.1 Latin America Leukemia Cancer Market Size by Application (2016-2021)
9.3.2 Latin America Leukemia Cancer Market Size by Application (2022-2027)
9.3.3 Latin America Leukemia Cancer Market Size by Application (2016-2027)
9.4 Latin America Leukemia Cancer Market Size by Country
9.4.1 Latin America Leukemia Cancer Market Size by Country (2016-2021)
9.4.2 Latin America Leukemia Cancer Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Leukemia Cancer Market Size (2016-2027)
10.2 Middle East & Africa Leukemia Cancer Market Size by Type
10.2.1 Middle East & Africa Leukemia Cancer Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Leukemia Cancer Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Leukemia Cancer Market Size by Type (2016-2027)
10.3 Middle East & Africa Leukemia Cancer Market Size by Application
10.3.1 Middle East & Africa Leukemia Cancer Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Leukemia Cancer Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Leukemia Cancer Market Size by Application (2016-2027)
10.4 Middle East & Africa Leukemia Cancer Market Size by Country
10.4.1 Middle East & Africa Leukemia Cancer Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Leukemia Cancer Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Leukemia Cancer Introduction
11.1.4 Biogen Revenue in Leukemia Cancer Business (2016-2021)
11.1.5 Biogen Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Leukemia Cancer Introduction
11.2.4 GSK Revenue in Leukemia Cancer Business (2016-2021)
11.2.5 GSK Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Leukemia Cancer Introduction
11.3.4 Novartis Revenue in Leukemia Cancer Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Leukemia Cancer Introduction
11.4.4 Pfizer Revenue in Leukemia Cancer Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Leukemia Cancer Introduction
11.5.4 Roche Revenue in Leukemia Cancer Business (2016-2021)
11.5.5 Roche Recent Development
11.6 Takeda Oncology
11.6.1 Takeda Oncology Company Details
11.6.2 Takeda Oncology Business Overview
11.6.3 Takeda Oncology Leukemia Cancer Introduction
11.6.4 Takeda Oncology Revenue in Leukemia Cancer Business (2016-2021)
11.6.5 Takeda Oncology Recent Development
11.7 Teva Pharmaceutical
11.7.1 Teva Pharmaceutical Company Details
11.7.2 Teva Pharmaceutical Business Overview
11.7.3 Teva Pharmaceutical Leukemia Cancer Introduction
11.7.4 Teva Pharmaceutical Revenue in Leukemia Cancer Business (2016-2021)
11.7.5 Teva Pharmaceutical Recent Development
11.8 Celgene
11.8.1 Celgene Company Details
11.8.2 Celgene Business Overview
11.8.3 Celgene Leukemia Cancer Introduction
11.8.4 Celgene Revenue in Leukemia Cancer Business (2016-2021)
11.8.5 Celgene Recent Development
11.9 Daiichi Sankyo
11.9.1 Daiichi Sankyo Company Details
11.9.2 Daiichi Sankyo Business Overview
11.9.3 Daiichi Sankyo Leukemia Cancer Introduction
11.9.4 Daiichi Sankyo Revenue in Leukemia Cancer Business (2016-2021)
11.9.5 Daiichi Sankyo Recent Development
11.10 EISAI
11.10.1 EISAI Company Details
11.10.2 EISAI Business Overview
11.10.3 EISAI Leukemia Cancer Introduction
11.10.4 EISAI Revenue in Leukemia Cancer Business (2016-2021)
11.10.5 EISAI Recent Development
11.11 Sunesis Pharmaceuticals
11.11.1 Sunesis Pharmaceuticals Company Details
11.11.2 Sunesis Pharmaceuticals Business Overview
11.11.3 Sunesis Pharmaceuticals Leukemia Cancer Introduction
11.11.4 Sunesis Pharmaceuticals Revenue in Leukemia Cancer Business (2016-2021)
11.11.5 Sunesis Pharmaceuticals Recent Development
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Details
11.12.2 Bristol-Myers Squibb Business Overview
11.12.3 Bristol-Myers Squibb Leukemia Cancer Introduction
11.12.4 Bristol-Myers Squibb Revenue in Leukemia Cancer Business (2016-2021)
11.12.5 Bristol-Myers Squibb Recent Development
11.13 Spectrum Pharmaceuticals
11.13.1 Spectrum Pharmaceuticals Company Details
11.13.2 Spectrum Pharmaceuticals Business Overview
11.13.3 Spectrum Pharmaceuticals Leukemia Cancer Introduction
11.13.4 Spectrum Pharmaceuticals Revenue in Leukemia Cancer Business (2016-2021)
11.13.5 Spectrum Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Leukemia Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiation Therapy
Table 4. Key Players of Targeted Therapy
Table 5. Key Players of Biological Therapy
Table 6. Key Players of Stem Cell Transplant
Table 7. Global Leukemia Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Leukemia Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Leukemia Cancer Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Leukemia Cancer Market Share by Regions (2016-2021)
Table 11. Global Leukemia Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Leukemia Cancer Market Share by Regions (2022-2027)
Table 13. Leukemia Cancer Market Trends
Table 14. Leukemia Cancer Market Drivers
Table 15. Leukemia Cancer Market Challenges
Table 16. Leukemia Cancer Market Restraints
Table 17. Global Leukemia Cancer Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Leukemia Cancer Market Share by Players (2016-2021)
Table 19. Global Top Leukemia Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leukemia Cancer as of 2020)
Table 20. Ranking of Global Top Leukemia Cancer Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Leukemia Cancer Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Leukemia Cancer Product Solution and Service
Table 24. Date of Enter into Leukemia Cancer Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Leukemia Cancer Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Leukemia Cancer Revenue Market Share by Type (2016-2021)
Table 28. Global Leukemia Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Leukemia Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Leukemia Cancer Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Leukemia Cancer Revenue Market Share by Application (2016-2021)
Table 32. Global Leukemia Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Leukemia Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Leukemia Cancer Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Leukemia Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Leukemia Cancer Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Leukemia Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Leukemia Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Leukemia Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Leukemia Cancer Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Leukemia Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Leukemia Cancer Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Leukemia Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Leukemia Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Leukemia Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Leukemia Cancer Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Leukemia Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Leukemia Cancer Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Leukemia Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Leukemia Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Leukemia Cancer Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Leukemia Cancer Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Leukemia Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Leukemia Cancer Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Leukemia Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Leukemia Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Leukemia Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Leukemia Cancer Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Leukemia Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Leukemia Cancer Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Leukemia Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Leukemia Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Leukemia Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 64. Biogen Company Details
Table 65. Biogen Business Overview
Table 66. Biogen Leukemia Cancer Product
Table 67. Biogen Revenue in Leukemia Cancer Business (2016-2021) & (US$ Million)
Table 68. Biogen Recent Development
Table 69. GSK Company Details
Table 70. GSK Business Overview
Table 71. GSK Leukemia Cancer Product
Table 72. GSK Revenue in Leukemia Cancer Business (2016-2021) & (US$ Million)
Table 73. GSK Recent Development
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Leukemia Cancer Product
Table 77. Novartis Revenue in Leukemia Cancer Business (2016-2021) & (US$ Million)
Table 78. Novartis Recent Development
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Leukemia Cancer Product
Table 82. Pfizer Revenue in Leukemia Cancer Business (2016-2021) & (US$ Million)
Table 83. Pfizer Recent Development
Table 84. Roche Company Details
Table 85. Roche Business Overview
Table 86. Roche Leukemia Cancer Product
Table 87. Roche Revenue in Leukemia Cancer Business (2016-2021) & (US$ Million)
Table 88. Roche Recent Development
Table 89. Takeda Oncology Company Details
Table 90. Takeda Oncology Business Overview
Table 91. Takeda Oncology Leukemia Cancer Product
Table 92. Takeda Oncology Revenue in Leukemia Cancer Business (2016-2021) & (US$ Million)
Table 93. Takeda Oncology Recent Development
Table 94. Teva Pharmaceutical Company Details
Table 95. Teva Pharmaceutical Business Overview
Table 96. Teva Pharmaceutical Leukemia Cancer Product
Table 97. Teva Pharmaceutical Revenue in Leukemia Cancer Business (2016-2021) & (US$ Million)
Table 98. Teva Pharmaceutical Recent Development
Table 99. Celgene Company Details
Table 100. Celgene Business Overview
Table 101. Celgene Revenue in Leukemia Cancer Business (2016-2021) & (US$ Million)
Table 102. Celgene Recent Development
Table 103. Daiichi Sankyo Company Details
Table 104. Daiichi Sankyo Business Overview
Table 105. Daiichi Sankyo Leukemia Cancer Product
Table 106. Daiichi Sankyo Revenue in Leukemia Cancer Business (2016-2021) & (US$ Million)
Table 107. Daiichi Sankyo Recent Development
Table 108. EISAI Company Details
Table 109. EISAI Business Overview
Table 110. EISAI Leukemia Cancer Product
Table 111. EISAI Revenue in Leukemia Cancer Business (2016-2021) & (US$ Million)
Table 112. EISAI Recent Development
Table 113. Sunesis Pharmaceuticals Company Details
Table 114. Sunesis Pharmaceuticals Business Overview
Table 115. Sunesis Pharmaceuticals Leukemia Cancer Product
Table 116. Sunesis Pharmaceuticals Revenue in Leukemia Cancer Business (2016-2021) & (US$ Million)
Table 117. Sunesis Pharmaceuticals Recent Development
Table 118. Bristol-Myers Squibb Company Details
Table 119. Bristol-Myers Squibb Business Overview
Table 120. Bristol-Myers Squibb Leukemia Cancer Product
Table 121. Bristol-Myers Squibb Revenue in Leukemia Cancer Business (2016-2021) & (US$ Million)
Table 122. Bristol-Myers Squibb Recent Development
Table 123. Spectrum Pharmaceuticals Company Details
Table 124. Spectrum Pharmaceuticals Business Overview
Table 125. Spectrum Pharmaceuticals Leukemia Cancer Product
Table 126. Spectrum Pharmaceuticals Revenue in Leukemia Cancer Business (2016-2021) & (US$ Million)
Table 127. Spectrum Pharmaceuticals Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Leukemia Cancer Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Radiation Therapy Features
Figure 4. Targeted Therapy Features
Figure 5. Biological Therapy Features
Figure 6. Stem Cell Transplant Features
Figure 7. Global Leukemia Cancer Market Share by Application: 2020 VS 2027
Figure 8. Acute Myeloid Leukaemia (AML) Case Studies
Figure 9. Chronic Myeloid Leukaemia (CML) Case Studies
Figure 10. Acute Lymphoblastic Leukaemia (ALL) Case Studies
Figure 11. Chronic Lymphocytic Leukaemia (CLL) Case Studies
Figure 12. Leukemia Cancer Report Years Considered
Figure 13. Global Leukemia Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Leukemia Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Leukemia Cancer Market Share by Regions: 2020 VS 2027
Figure 16. Global Leukemia Cancer Market Share by Regions (2022-2027)
Figure 17. Global Leukemia Cancer Market Share by Players in 2020
Figure 18. Global Top Leukemia Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leukemia Cancer as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Leukemia Cancer Revenue in 2020
Figure 20. Global Leukemia Cancer Revenue Market Share by Type (2016-2021)
Figure 21. Global Leukemia Cancer Revenue Market Share by Type (2022-2027)
Figure 22. North America Leukemia Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Leukemia Cancer Market Share by Type (2016-2027)
Figure 24. North America Leukemia Cancer Market Share by Application (2016-2027)
Figure 25. North America Leukemia Cancer Market Share by Country (2016-2027)
Figure 26. United States Leukemia Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Leukemia Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Leukemia Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Leukemia Cancer Market Share by Type (2016-2027)
Figure 30. Europe Leukemia Cancer Market Share by Application (2016-2027)
Figure 31. Europe Leukemia Cancer Market Share by Country (2016-2027)
Figure 32. Germany Leukemia Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Leukemia Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Leukemia Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Leukemia Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Leukemia Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Leukemia Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Leukemia Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Leukemia Cancer Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Leukemia Cancer Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Leukemia Cancer Market Share by Region (2016-2027)
Figure 42. China Leukemia Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Leukemia Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Leukemia Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Leukemia Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Leukemia Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Leukemia Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Leukemia Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Leukemia Cancer Market Share by Type (2016-2027)
Figure 50. Latin America Leukemia Cancer Market Share by Application (2016-2027)
Figure 51. Latin America Leukemia Cancer Market Share by Country (2016-2027)
Figure 52. Mexico Leukemia Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Leukemia Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Leukemia Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Leukemia Cancer Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Leukemia Cancer Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Leukemia Cancer Market Share by Country (2016-2027)
Figure 58. Turkey Leukemia Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Leukemia Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Leukemia Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Biogen Revenue Growth Rate in Leukemia Cancer Business (2016-2021)
Figure 62. GSK Revenue Growth Rate in Leukemia Cancer Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Leukemia Cancer Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in Leukemia Cancer Business (2016-2021)
Figure 65. Roche Revenue Growth Rate in Leukemia Cancer Business (2016-2021)
Figure 66. Takeda Oncology Revenue Growth Rate in Leukemia Cancer Business (2016-2021)
Figure 67. Teva Pharmaceutical Revenue Growth Rate in Leukemia Cancer Business (2016-2021)
Figure 68. Celgene Revenue Growth Rate in Leukemia Cancer Business (2016-2021)
Figure 69. Daiichi Sankyo Revenue Growth Rate in Leukemia Cancer Business (2016-2021)
Figure 70. EISAI Revenue Growth Rate in Leukemia Cancer Business (2016-2021)
Figure 71. Sunesis Pharmaceuticals Revenue Growth Rate in Leukemia Cancer Business (2016-2021)
Figure 72. Bristol-Myers Squibb Revenue Growth Rate in Leukemia Cancer Business (2016-2021)
Figure 73. Spectrum Pharmaceuticals Revenue Growth Rate in Leukemia Cancer Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

---